Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the single cell multiomics market grown over the years?

The market size for single cell multiomics has experienced substantial growth in the past few years. Its value will increase from $3.97 billion in 2024 to $4.85 billion in 2025, which represents a compound annual growth rate (CAGR) of 22.1%. The significant growth during the historic period is a result of enhanced research funding, increased demand for customised medication, progress in cancer research, a rise in chronic diseases prevalence, and expansion in academic and clinical research domains.

What Is the forecasted market size and growth rate for the single cell multiomics market?

Anticipations hint at a significant surge in the single cell multiomics market size in the forthcoming years. The market valuation is projected to reach a whopping $10.69 billion by the year 2029, growing at a compound annual growth rate (CAGR) of 21.8%. Factors contributing to the growth during the period under observation include the rising implementation of precision medicine, mounting focus on rare diseases, increasing interest in stem cell research, escalation in clinical research investigations, and the growing need for high throughput screening. Noteworthy trends for the said forecast period encompass the creation of multi-parameter profiling instruments, progress in spatial transcriptomics, the utilization of high-definition imaging methods, incorporation of comprehensive omics databases, and the inception of cutting-edge bioinformatics solutions.

Get your single cell multiomics market report here!

https://www.thebusinessresearchcompany.com/report/single-cell-multiomics-global-market-report

What are the major factors driving growth in the single cell multiomics market?

The surge in the need for precision medicine is anticipated to boost the expansion of the single cell multiomics market in the future. Precision medicine is a medical model which customizes healthcare policies and treatments based on the distinct attributes of each patient. This rise is energized by advancements in the realm of genomic research, improved ability for data analysis, and an intensified comprehension of the perks of personalized healthcare. Single cell multiomics lend in-depth understanding into cellular diversity and molecular processes, making way for the creation of highly personalized treatments to match the distinct cellular profiles of each patient. For instance, the Personalized Medicine Coalition, a professional membership organization located in the United States, reported that in 2022 there were 12 new personalized medicines that were approved accounting for roughly 34% of all freshly approved treatments, reflecting a significant leap from earlier years. Thus, the intensified need for precision medicine is fuelling the expansion of the single cell multiomics market.

What key areas define the segmentation of the global single cell multiomics Market?

The single cell multiomics market covered in this report is segmented –

1) By Type: Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics

2) By Technique: Single Cell Isolation And Dispensing, Single Cell Analysis

3) By Application: Oncology, Cell Biology, Neurology, Immunology, Stem Cell Research

4) By End User: Academic Institutes, Contract Research Organizations, Pharmaceutical And Biotech Companies

Subsegments:

1) By Single Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single Cell DNA Amplification Techniques, Genomic Analysis Platforms

2) By Single Cell Proteomics: Mass Spectrometry-Based Techniques, Protein Microarrays, Enzyme-Linked Immunosorbent Assays (ELISA), Single Cell Protein Analysis Platforms

3) By Single Cell Transcriptomics: Single Cell RNA Sequencing (scRNA-seq), RNA Amplification Techniques, Microfluidics-Based Transcriptomics, Transcriptome Analysis Tools

4) By Single Cell Metabolomics: Mass Spectrometry For Metabolite Analysis, Nuclear Magnetic Resonance (NMR) Techniques, Liquid Chromatography For Metabolomics, Metabolite Profiling Tools

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20630&type=smp

What are the top market players propelling the growth of the single cell multiomics industry?

Major companies operating in the single cell multiomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Illumina Inc., BioRad Laboratories Inc., QIAGEN N.V., BioTechne Corporation, Miltenyi Biotec BV & Co KG, BGI Genomics Co Ltd., 10x Genomics Inc., Molecular Devices LLC, NanoString Technologies Inc., Standard BioTools Inc., Akoya Biosciences Inc., Takara Bio Inc., Synthego Corporation, Mission Bio Inc., DeepCell Inc., RareCyte Inc., Parse Biosciences Inc., Dolomite Bio Ltd., Stilla Technologies SAS, NanoCellect Biomedical Inc., Epicypher Inc., Scipio Biosciences SAS

What are the key trends shaping the future of the single cell multiomics market?

Leading firms in the single cell multiomics sector are pioneering single-cell multiomics tests to improve the precision and clarity of cell analysis. They allow researchers to gain a deeper understanding of multifaceted biological systems, pinpoint uncommon cell groupings, and customize precision medicine techniques by incorporating thorough molecular data from individual cells. For instance, Mission Bio, a biotech firm based in the United States, launched the Tapestri Single-cell Multiple Myeloma Multiomics Solution in June 2024. This scheme provides a thorough profiling of multiple myeloma at a single-cell level of detail. Consequently, this facilitates translational researchers and drug creators to thoroughly examine the molecular and cellular configuration during myeloid progression, comprehend therapy resistance, and recognize disease evolution initiators from early stages such as monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20630

What regions are dominating the single cell multiomics market growth?

North America was the largest region in the single cell multiomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single cell multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Flow Cytometry Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/flow-cytometry-global-market-report

Flow Cytometry In Oncology And Immunology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

Stem Cell Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: